Therapeutic Asset Ratings
1,482 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Anti-Thymoglobulin, Rabbit
Metachromatic Leukodystrophy
Masonic Cancer Center, University of Minnesota
P2/3
B
(62)
Anti-Thymoglobulin, Rabbit
Myelofibrosis
Fred Hutchinson Cancer Center
P2/3
B
(62)
Apg-2575
Lisaftoclax
M.D. Anderson Cancer Center
P2/3
B
(62)
Atezolizumab
Colorectal Neoplasm
Cancer Research UK
P2/3
B
(62)
Atezolizumab
Metastatic Malignant Neoplasm
Genentech, Inc.
P2/3
B
(62)
Atezolizumab
Ovarian Endometrioid Adenocarcinoma
University Health Network, Toronto
P2/3
B
(62)
Atezolizumab
Neoplasm
Hoffmann-La Roche
P2/3
B
(62)
Benadryl
B-Cell Acute Lymphoblastic Leukemia
Merck Sharp & Dohme LLC
P2/3
B
(62)
Busulphan
Conditioning
First Affiliated Hospital Xi'an Jiaotong University
P2/3
B
(62)
Cobimetinib
Hematopoietic And Lymphoid System Neoplasm
Cancer Research UK
P2/3
B
(62)
Cobolimab
Non-Small Cell Lung Carcinoma
GlaxoSmithKline
P2/3
B
(62)
Cyclophosphamide
Conditioning
First Affiliated Hospital Xi'an Jiaotong University
P2/3
B
(62)
Cyclophosphamide
Metastatic Bladder Giant Cell Urothelial Carcinoma
Fred Hutchinson Cancer Center
P2/3
B
(62)
Cytosin-Arabinosid
Lisaftoclax
M.D. Anderson Cancer Center
P2/3
B
(62)
Dabrafenib
Hematopoietic And Lymphoid System Neoplasm
Cancer Research UK
P2/3
B
(62)
DARATUMUMAB
T-Cell Acute Lymphoblastic Leukemia
Children's Oncology Group
P2/3
B
(62)
Decitabine
Leukemia
Dana-Farber Cancer Institute
P2/3
B
(62)
Eloxatin
Peritoneal Cancer
Arjun Mittra
P2/3
B
(62)
ENFORTUMAB VEDOTIN (fully human monoclonal antibody conjugated to a cytotoxic agent monomethyl auristatin E (MMAE) targeting nectin-4)
Infiltrating Bladder Urothelial Carcinoma
Fred Hutchinson Cancer Center
P2/3
B
(62)
Epirubicin
Metastatic Bladder Giant Cell Urothelial Carcinoma
Fred Hutchinson Cancer Center
P2/3
B
(62)
ETOPOSIDE
Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma Of The Elderly
University of Washington
P2/3
B
(62)
FENTANYL
B-All
Merck Sharp & Dohme LLC
P2/3
B
(62)
gsk1120212
Hematopoietic And Lymphoid System Neoplasm
Cancer Research UK
P2/3
B
(62)
Hycamtin
Ovarian Clear Cell Adenocarcinoma
National Cancer Institute (NCI)
P2/3
B
(62)
Hycamtin
Ovarian Endometrioid Adenocarcinoma
National Cancer Institute (NCI)
P2/3
B
(62)
Showing 326 to 350 of 1,482 assets
Previous
Page 14 of 60
Next